Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents

Published:2016-06-01 Issue:4 Volume:88 Page:542-555
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Jiang Yuqi¹,Li Xiaoyang¹,Wang Xue¹,Wang Zhonglan¹,Zhang Jian²,Wu Jingde¹,Xu Wenfang¹

Affiliation:

1. Department of Medicinal Chemistry; School of Pharmaceutical Sciences; Shandong University; Ji'nan Shandong China

2. College of Pharmacy; Weifang Medical University; Wei'fang Shandong China

Funder

National Major Scientific and Technological Special Project for ‘Significant New Drugs Development’ of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.12778/fullpdf

Reference26 articles.

1. PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia

2. 13-Cis-retinoic acid: Pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer

3. Retinoid pathway and cancer therapeutics

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure–activity relationship (q-RASAR) and pharmacophore modeling;Molecular Diversity;2024-06-13

2. Discovery of novel biphenyl-sulfonamide analogues as NLRP3 inflammasome inhibitors;Bioorganic Chemistry;2024-05

3. Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease;Ageing Research Reviews;2023-03

4. Reduction BACE1 expression via suppressing NF-κB mediated signaling by Tamibarotene in a mouse model of Alzheimer’s disease;IBRO Neuroscience Reports;2021-06

5. Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy;Cancers;2019-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3